Surmodics
SRDX
SRDX was delisted on the 18th of November, 2025.
109 hedge funds and large institutions have $269M invested in Surmodics in 2013 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 34 increasing their positions, 49 reducing their positions, and 13 closing their positions.
25% more call options, than puts
Call options by funds: $663K | Put options by funds: $529K
0% more capital invested
Capital invested by funds: $268M → $269M (+$873K)
4% less funds holding
Funds holding: 114 → 109 (-5)
31% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 49
31% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$2.51M |
| 2 |
TA
Teton Advisors
Rye,
New York
|
+$1.32M |
| 3 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$1.2M |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$944K |
| 5 |
WA
Whitebox Advisors
Minneapolis,
Minnesota
|
+$851K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$2.99M |
| 2 |
Morgan Stanley
New York
|
-$1.21M |
| 3 |
BG
BlackRock Group
London,
United Kingdom
|
-$1.01M |
| 4 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
-$975K |
| 5 |
Charles Schwab
San Francisco,
California
|
-$878K |
SRDX Hedge Fund Activity: Q4 2013 in Review
109 of the 3,459 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q4 2013, worth a combined $269M — up 0.33% from $268M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of SRDX and 9 opened new positions — a net loss of 4 holders — while 49 trimmed existing stakes and 34 added.
The largest buyer was Wellington Management Group, opening a new position worth an estimated $2.51M. The largest seller was TFS Capital, cutting an estimated $2.99M.
- 109 institutional investors held Surmodics (SRDX) as of Q4 2013, down from 114 in Q3 2013.
- Funds reported $269M of Surmodics stock for Q4 2013, up 0.33% quarter-over-quarter.
- 9 funds opened new Surmodics positions in Q4 2013 and 13 closed out, a net change of -4 holders.
- The largest Surmodics buyer in Q4 2013 was Wellington Management Group, an estimated $2.51M added.
- The largest Surmodics seller in Q4 2013 was TFS Capital, an estimated $2.99M sold.
Based on aggregated 13F filings for Q4 2013.